Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$114.22 - $140.1 $1.8 Million - $2.21 Million
15,761 Added 53.4%
45,278 $6.28 Million
Q4 2023

Feb 14, 2024

BUY
$75.49 - $124.16 $1.4 Million - $2.3 Million
18,549 Added 169.12%
29,517 $3.66 Million
Q3 2023

Nov 14, 2023

SELL
$86.06 - $137.93 $22.6 Million - $36.3 Million
-263,139 Reduced 96.0%
10,968 $1.02 Million
Q2 2023

Aug 14, 2023

BUY
$112.47 - $130.98 $4.81 Million - $5.6 Million
42,737 Added 18.47%
274,107 $35.2 Million
Q1 2023

May 15, 2023

BUY
$104.0 - $122.92 $2.85 Million - $3.37 Million
27,438 Added 13.45%
231,370 $26.9 Million
Q4 2022

Feb 14, 2023

BUY
$84.98 - $122.67 $14.7 Million - $21.3 Million
173,288 Added 565.49%
203,932 $23.1 Million
Q3 2022

Nov 14, 2022

SELL
$76.35 - $94.18 $5.55 Million - $6.85 Million
-72,711 Reduced 70.35%
30,644 $2.47 Million
Q2 2022

Aug 15, 2022

BUY
$67.99 - $132.89 $4.66 Million - $9.11 Million
68,520 Added 196.7%
103,355 $7.7 Million
Q1 2022

May 16, 2022

BUY
$94.08 - $130.2 $690,547 - $955,667
7,340 Added 26.7%
34,835 $17.8 Million
Q4 2021

Feb 14, 2022

BUY
$129.87 - $162.82 $3.57 Million - $4.48 Million
27,495 New
27,495 $14.8 Million
Q1 2021

May 17, 2021

SELL
$84.79 - $104.74 $1.46 Million - $1.8 Million
-17,196 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$78.0 - $104.5 $4.69 Million - $6.29 Million
-60,180 Reduced 77.78%
17,196 $6.36 Million
Q3 2020

Nov 16, 2020

BUY
$95.51 - $112.95 $3.62 Million - $4.28 Million
37,897 Added 95.99%
77,376 $31.9 Million
Q2 2020

Aug 14, 2020

SELL
$62.68 - $105.34 $9.12 Million - $15.3 Million
-145,560 Reduced 78.66%
39,479 $16 Million
Q1 2020

May 14, 2020

BUY
$47.79 - $75.63 $1.07 Million - $1.69 Million
22,307 Added 13.71%
185,039 $49.8 Million
Q4 2019

Feb 14, 2020

BUY
$36.62 - $57.29 $5.96 Million - $9.32 Million
162,732 New
162,732 $35.6 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $26B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Worldquant Millennium Advisors LLC Portfolio

Follow Worldquant Millennium Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Worldquant Millennium Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Worldquant Millennium Advisors LLC with notifications on news.